FIXX Homology Medicines Inc.

Homology Medicines is an US based genetic medicines company. It is dedicated towards translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases.

$5.79  -0.04 (-0.69%)
As of 10/26/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/28/2018
Outstanding shares:  57,088,143
Average volume:  460,677
Market cap:   $342,528,858
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    438083107
ISIN:        US4380831077
Valuation   (See tab for details)
PE ratio:   -3.71
PB ratio:   1.48
PS ratio:   10.37
Return on equity:   -39.90%
Net income %:   -271.18%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy